Tranexamic Acid in Abdominoplasty.

Phase 4 Completed 60 enrolled Poznan University of Medical Sciences

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators prepared a novel tranexamic acid (TXA) study designed to estimate the quantity of blood loss in patients undergoing abdominoplasty surgery. This study aims to quantify blood loss during abdominoplasty with and without TXA. The central hypothesis is that TXA administration reduces blood loss and fibrinolysis in patients undergoing abdominoplasty surgery.

Timeline

Start: 2023-10-17
Primary completion: 2025-10-10
Completion: 2025-10-10

Publications

Kolasinski J, Reysner T, Kolenda M, Kolacz S, Reysner M. Efficacy and safety of intravenous tranexamic acid in elective abdominoplasty: A randomized, triple-blinded, placebo-controlled clinical trial. J Plast Reconstr Aesthet Surg. 2026 Feb;113:693-699. doi: 10.1016/j.bjps.2025.11.055. Epub 2025 Dec 5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Tranexamic Acid	Small molecule	10 mg/kg	Intravenous

Tranexamic Acid in Abdominoplasty.

Summary

Timeline

Publications

Drugs

Indications